![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MAST4 |
Gene summary for MAST4 |
![]() |
Gene information | Species | Human | Gene symbol | MAST4 | Gene ID | 375449 |
Gene name | microtubule associated serine/threonine kinase family member 4 | |
Gene Alias | MAST4 | |
Cytomap | 5q12.3 | |
Gene Type | protein-coding | GO ID | GO:0006464 | UniProtAcc | J3QT34 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
375449 | MAST4 | CA_HPV_1 | Human | Cervix | CC | 1.75e-12 | -3.15e-01 | 0.0264 |
375449 | MAST4 | CCI_1 | Human | Cervix | CC | 6.06e-03 | 1.15e+00 | 0.528 |
375449 | MAST4 | CCI_2 | Human | Cervix | CC | 3.87e-08 | 1.17e+00 | 0.5249 |
375449 | MAST4 | CCI_3 | Human | Cervix | CC | 2.08e-14 | 1.22e+00 | 0.516 |
375449 | MAST4 | AEH-subject1 | Human | Endometrium | AEH | 2.34e-19 | 6.03e-01 | -0.3059 |
375449 | MAST4 | AEH-subject2 | Human | Endometrium | AEH | 4.25e-10 | 5.01e-01 | -0.2525 |
375449 | MAST4 | AEH-subject3 | Human | Endometrium | AEH | 5.79e-19 | 6.19e-01 | -0.2576 |
375449 | MAST4 | AEH-subject4 | Human | Endometrium | AEH | 2.29e-10 | 5.55e-01 | -0.2657 |
375449 | MAST4 | AEH-subject5 | Human | Endometrium | AEH | 2.84e-52 | 1.11e+00 | -0.2953 |
375449 | MAST4 | EEC-subject1 | Human | Endometrium | EEC | 2.51e-13 | 5.45e-01 | -0.2682 |
375449 | MAST4 | EEC-subject2 | Human | Endometrium | EEC | 1.33e-31 | 7.71e-01 | -0.2607 |
375449 | MAST4 | EEC-subject3 | Human | Endometrium | EEC | 1.34e-05 | 3.52e-01 | -0.2525 |
375449 | MAST4 | EEC-subject4 | Human | Endometrium | EEC | 2.40e-16 | 5.95e-01 | -0.2571 |
375449 | MAST4 | EEC-subject5 | Human | Endometrium | EEC | 1.16e-09 | 4.60e-01 | -0.249 |
375449 | MAST4 | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 1.49e-03 | 2.04e-01 | -0.1869 |
375449 | MAST4 | GSM6177620_NYU_UCEC1_lib2_lib2 | Human | Endometrium | EEC | 9.39e-03 | 1.71e-01 | -0.1875 |
375449 | MAST4 | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 1.95e-03 | 6.87e-02 | -0.1883 |
375449 | MAST4 | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 3.58e-02 | 2.12e-01 | -0.1934 |
375449 | MAST4 | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 9.43e-09 | 1.11e-01 | -0.1917 |
375449 | MAST4 | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 2.26e-06 | 1.21e-01 | -0.1916 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00181057 | Cervix | CC | peptidyl-serine phosphorylation | 63/2311 | 315/18723 | 6.65e-05 | 9.47e-04 | 63 |
GO:00182096 | Cervix | CC | peptidyl-serine modification | 66/2311 | 338/18723 | 9.58e-05 | 1.25e-03 | 66 |
GO:00181058 | Endometrium | AEH | peptidyl-serine phosphorylation | 50/2100 | 315/18723 | 7.20e-03 | 4.13e-02 | 50 |
GO:00182099 | Esophagus | ESCC | peptidyl-serine modification | 196/8552 | 338/18723 | 3.07e-06 | 3.47e-05 | 196 |
GO:001810515 | Esophagus | ESCC | peptidyl-serine phosphorylation | 184/8552 | 315/18723 | 3.22e-06 | 3.61e-05 | 184 |
GO:00181055 | Liver | NAFLD | peptidyl-serine phosphorylation | 63/1882 | 315/18723 | 7.45e-08 | 6.60e-06 | 63 |
GO:00182094 | Liver | NAFLD | peptidyl-serine modification | 64/1882 | 338/18723 | 4.65e-07 | 2.89e-05 | 64 |
GO:001810511 | Liver | HCC | peptidyl-serine phosphorylation | 169/7958 | 315/18723 | 3.86e-05 | 3.81e-04 | 169 |
GO:001820911 | Liver | HCC | peptidyl-serine modification | 177/7958 | 338/18723 | 1.45e-04 | 1.17e-03 | 177 |
GO:00181056 | Lung | IAC | peptidyl-serine phosphorylation | 69/2061 | 315/18723 | 1.48e-08 | 1.87e-06 | 69 |
GO:00182095 | Lung | IAC | peptidyl-serine modification | 70/2061 | 338/18723 | 1.23e-07 | 1.10e-05 | 70 |
GO:001810512 | Lung | AIS | peptidyl-serine phosphorylation | 60/1849 | 315/18723 | 4.75e-07 | 3.64e-05 | 60 |
GO:001820912 | Lung | AIS | peptidyl-serine modification | 61/1849 | 338/18723 | 2.49e-06 | 1.41e-04 | 61 |
GO:001810521 | Lung | MIAC | peptidyl-serine phosphorylation | 37/967 | 315/18723 | 2.73e-06 | 3.12e-04 | 37 |
GO:001820921 | Lung | MIAC | peptidyl-serine modification | 37/967 | 338/18723 | 1.38e-05 | 9.86e-04 | 37 |
GO:00182098 | Oral cavity | OSCC | peptidyl-serine modification | 175/7305 | 338/18723 | 1.09e-06 | 1.46e-05 | 175 |
GO:001810510 | Oral cavity | OSCC | peptidyl-serine phosphorylation | 164/7305 | 315/18723 | 1.51e-06 | 1.99e-05 | 164 |
GO:001810514 | Oral cavity | EOLP | peptidyl-serine phosphorylation | 84/2218 | 315/18723 | 3.32e-13 | 1.05e-10 | 84 |
GO:001820914 | Oral cavity | EOLP | peptidyl-serine modification | 87/2218 | 338/18723 | 1.07e-12 | 2.46e-10 | 87 |
GO:001810522 | Oral cavity | NEOLP | peptidyl-serine phosphorylation | 70/2005 | 315/18723 | 1.97e-09 | 1.24e-07 | 70 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MAST4 | SNV | Missense_Mutation | c.1876N>A | p.Glu626Lys | p.E626K | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-Q1-A73O-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | ||
MAST4 | SNV | Missense_Mutation | c.176N>C | p.Arg59Thr | p.R59T | protein_coding | tolerated_low_confidence(0.26) | benign(0.078) | TCGA-UC-A7PF-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | ||
MAST4 | SNV | Missense_Mutation | c.6812N>T | p.Pro2271Leu | p.P2271L | protein_coding | tolerated_low_confidence(0.17) | benign(0.007) | TCGA-A6-3809-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
MAST4 | SNV | Missense_Mutation | rs773097084 | c.1826G>A | p.Arg609Gln | p.R609Q | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A6-6141-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | 5-fu | SD | |
MAST4 | SNV | Missense_Mutation | c.7343C>A | p.Ser2448Tyr | p.S2448Y | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.813) | TCGA-A6-6141-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | 5-fu | SD | ||
MAST4 | SNV | Missense_Mutation | c.2309G>T | p.Gly770Val | p.G770V | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-A6-A56B-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | fluorouracil | PD | ||
MAST4 | SNV | Missense_Mutation | c.1055G>A | p.Arg352His | p.R352H | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-3492-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
MAST4 | SNV | Missense_Mutation | novel | c.7079A>G | p.Gln2360Arg | p.Q2360R | protein_coding | tolerated_low_confidence(0.32) | benign(0.098) | TCGA-AA-3492-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MAST4 | SNV | Missense_Mutation | rs767219421 | c.5950N>A | p.Glu1984Lys | p.E1984K | protein_coding | deleterious_low_confidence(0.01) | benign(0.071) | TCGA-AA-3672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
MAST4 | SNV | Missense_Mutation | c.5333A>C | p.Glu1778Ala | p.E1778A | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.986) | TCGA-AA-3710-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |